Pharmac's cardiovascular team recommends funding Wegovy for some people
Full story
The cardiovascular team at Pharmac recommends funding for the drug Wegovy for specific individuals. While the medication is currently used in New Zealand, it remains unfunded. Consequently, patients are required to pay for the treatment themselves.
The drug is already in use in New Zealand, but unfunded, meaning patients must cover the cost.